1. Choi YJ, Oh IK, Oh JR, Huh K. Intravitreal versus posterior sub-tenon injection of triamcinolone acetonide for diabetic macular edema. Korean J Ophthalmol. 2006; 20:205–9.
Article
2. Ozdek S, Deren YT, Gurelik G, Hasanreisoglu B. Posterior sub-tenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res. 2008; 40:26–31.
Article
3. Kim YJ, Kang SW, Ahn BH, Ham DI. The results of posterior sub-tenon steroid injection in uveitis patients. J Korean Ophthalmol Soc. 2003; 44:66–72.
4. Jea SY, Byon IS, Oum BS. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis. Korean J Ophthalmol. 2006; 20:99–103.
Article
5. Giles CL. Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol. 1974; 77:438–41.
Article
6. Ellis PP. Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol. 1978; 85:352–6.
Article
7. Nozik RA. Orbital rim fat atrophy after repository periocular corticosteroid injection. Am J Ophthalmol. 1976; 82:928–30.
Article
8. Kusaka S, Ikuno Y, Ohguro N, et al. Orbital infection following posterior subtenon triamcinolone injection. Acta Ophthalmol Scand. 2007; 85:692–3.
Article
9. Oh IK, Baek S, Huh K, Oh J. Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol. 2007; 245:164–6.
Article
10. Kuo HK, Lai IC, Fang PC, Teng MC. Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis. Chang Gung Med J. 2005; 28:85–9.
11. Lafranco Dafflon ML, Tran VT, Guex-Crosier Y, Herbort CP. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefe's Arch Clin Exp Ophthalmol. 1999; 237:289–95.
Article
12. Bui Quoc E, Bodaghi B, Adam R, et al. Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis. J Fr Ophtalmol. 2002; 25:1048–56.
13. Mueller AJ, Jian G, Banker AS, et al. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. Am J Ophthalmol. 1998; 125:158–63.
Article
14. Helm CJ, Holland GN. The effect of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995; 120:55–64.
15. Yamamoto Y, Komatsu T, Koura Y, et al. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmol. 2008; 43:42–7.
Article
16. Iwao K, Inatani M, Kawaji T, et al. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma. 2007; 16:251–6.
Article
17. Hirooka K, Shiraga F, Tanaka S, et al. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol. 2006; 50:235–8.
Article
18. Shimura M, Yasuda K, Nakazawa T, et al. Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol. 2009; 247:907–12.
Article
19. Inatani M, Iwao K, Kawaji T, et al. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retro-spective case-control study. Am J Ophthalmol. 2008; 145:676–81.
Article
20. Levin DS, Han DP, Dev S, et al. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am J Ophthalmol. 2002; 133:196–202.
Article
21. Kim WJ, Park YH. The intraocular pressure rise secondary to sub-tenon's injection of triamcinolone after intravitreal injection. J Korean Ophthalmol Soc. 2008; 49:91–7.
Article
22. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999; 18:629–67.
Article
23. Hernandez MR, Wenk EJ, Weinstein BI, et al. Glucocorticoid target cells in human outflow pathway: autopsy and surgical specimens. Invest Ophthalmol Vis Sci. 1983; 24:1612–6.
24. Tawara A, Tou N, Kubota T, et al. Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008; 246:1021–8.
Article
25. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009; 88:752–9.
Article
26. Hirano Y, Ito T, Nozaki M, et al. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. Jpn J Ophthalmol. 2009; 53:519–22.
Article
27. Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol. 1976; 82:90–3.
Article
28. Okka M, Bozkurt B, Kerimoglu H, et al. Control of steroid-induced glaucoma with surgical excision of sub-Tenon triamcinolone acetonide deposits: a clinical and biochemical approach. Can J Ophthalmol. 2010; 45:621–6.
Article
29. Yuki K, Inoue M, Shiba D, et al. Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide. Clin Ophthalmol. 2010; 26:247–9.
30. Mills DW, Siebert LF, Climenhaga DB. Depot triamcinolone-induced glaucoma. Can J Ophthalmol. 1986; 21:150–2.
31. Aydin A, Akin T, Bilge AH. Management of persistent glaucoma secondary to depot methylprednisolone. Ophthalmic Surg Lasers Imaging. 2007; 38:399–401.
Article
32. Akduman L, Kolker AE, Black DL, et al. Treatment of persistent glaucoma secondary to periocular corticosteroids. Am J Ophthalmol. 1996; 122:275–7.
Article
33. Kalina PH, Erie JC, Rosenbaum L. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995; 113:867–9.
Article
34. Kalina RE. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969; 81:788–90.
Article
35. Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica. 2005; 219:1–10.
Article